Home › Biotechnology
Biotechnology Market Research Reports & Consulting
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End-User, and Region - Global Forecast to 2025The Cell Expansion Market is expected to grow from USD 14.9 billion in 2020 to USD 30.1 billion by 2025, at a CAGR of 15.1% during the forecast period. Some of the leading players in the cell expansion market include Thermo Fisher Scientific, Inc. (US), Danaher (US), Becton, Dickinson and Company (US), Lonza (Switzerland), Corning, Inc. (US), Merck KGaA (Germany), Sartorius Stedim Biotech (France), Getinge AB (Sweden) Terumo Corporation (Japan), and Miltenyi Biotec (Germany) |
June 2020 | $ 4950 |
|
Biopreservation Market by Type (Media (Sera), Equipment (Thawing Equipment, Alarms, Freezers)), Biospecimen (Human Tissue, Stem Cells, Organs), Application (Therapeutic, Research, Clinical Trials), End User (Hospitals, Biobank) - Global Forecast to 2025The Biopreservation Market is expected to grow from USD 3.1 billion in 2020 to USD 4.9 billion by 2025, at a CAGR of 9.1% during the forecast period. The prominent players in this market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), and Avantor, Inc. (US) ThermoGenesis Holdings, Inc. (US), Bio-Techne Corporation (US), BioLife Solutions, Inc. (US), Exact Sciences Corporation (US), (US), Worthington Industries, Inc. (US), and Chart Industries, Inc. (US). |
June 2020 | $ 4950 |
|
Aseptic Sampling Market by Type (Manual [Type (Traditional, Single-use), Product (Bags, Bottles, Syringes, Accessories)], Automatic), Application (Upstream, Downstream), Technique (Off-line, On-line), End User (R&D, CMO, CRO) - Global Forecast to 2025The global aseptic sampling market is projected to reach USD 474 million by 2025 from USD 264 million in 2020, at a CAGR of 12.4%. Market growth is driven mainly by the increasing demand for biopharmaceuticals, stringent government regulations to ensure drug safety, and funding to support life sciences research activities. |
June 2020 | $ 4950 |
|
Cell Counting Market by Product (Instruments (Spectrophotometer, Hemocytometer, Flow Cytometer, Hematology Analyzers), Consumables (Reagent, Microplate)), Cancer, Stem Cell Research, End User (Pharmaceutical, Hospital, Research) - Global Forecast to 2025The global cell counting market is expected to grow USD 14.5 billion in 2025, at a CAGR of 6.7 % during the forecast period. The major companies in the cell counting market are Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), and Bio-Rad Laboratories (US). |
June 2020 | $ 4950 |
|
Protein Crystallization & Crystallography Market by Technology (NMR, X-Ray Crystallography), Product & Service (Instrument (Liquid Handling (Automated)), Consumable (Reagent, Microplate) End User, and Region - Global Forecast to 2025The Protein Crystallization & Crystallography Market is expected to grow from USD 1.1 billion in 2020 to USD 1.7 billion by 2025, at a CAGR of 8.9% during the forecast period. The major companies in the protein crystallization and crystallography market are Rigaku Corporation (Japan), Hampton Research (US), Jena Bioscience GmbH (Germany), and Bruker Corporation (US). |
June 2020 | $ 4950 |
|
Membrane Chromatography Market by Product (Consumables (Syringe Filters, Spin Column), Accessories), Technique (Ion Exchange, Affinity), Operation Mode (Flow Through), End User (Pharmaceutical & Biopharmaceutical Companies, CROs) - Global Forecast to 2025The Membrane Chromatography Market is expected to grow from USD 198 million in 2020 to USD 408 million by 2025, at a CAGR of 15.5% during the forecast period. The major companies in the global membrane chromatography market are Sartorius AG (Germany), Danaher Corporation (US), Merck Millipore (Germany), Thermo Fisher Scientific (US), and 3M Company (US). |
June 2020 | $ 4950 |
|
Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User and Region - Global Forecast to 2025The global genome editing/genome engineering market size is expected to grow USD 11.2 billion in 2025 from USD 5.1 billion in 2020, at a CAGR of 17.0 % during the forecast period. The major companies in the genome editing/genome engineering market include Thermo Fisher Scientific (US), Merck & Co (Germany), Horizon Discovery Limited (UK), Lonza (Switzerland), GenScript (US), Eurofins Scientific (Luxembourg) and Sangamo Therapeutics (US). |
June 2020 | $ 4950 |
|
Nucleic Acid Isolation and Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Precision Medicine), End User (Academic) - Global Forecast to 2025The global nucleic acid isolation and purification market is expected to grow USD 3.2 billion in 2020, at a CAGR of 8.9% during the forecast period. QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), and F. Hoffmann-La Roche Ltd. (Switzerland) are the key players operating in the nucleic acid isolation and purification market. Other prominent players in this market include Promega Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Danaher Corporation (US), GE Healthcare (US), Illumina, Inc. (US), Merck KGaA (Germany), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), Omega Bio-tek (US), Genaxxon Bioscience GmbH (Germany), 3B BlackBio Biotech India Limited (India), Invitek Molecular (Germany), BioVision (US), and Analytik Jena AG (Germany). |
May 2020 | $ 4950 |
|
Protein Expression Market by Type (Escherichia Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus and Cell-free), Products (Reagents, Competent Cells, Instruments, Services), Application, End-User and Region - Global Forecast to 2025The Protein Expression Market is expected to grow from USD 2.2 billion in 2020 to USD 4.1 billion by 2025, at a CAGR of 13.2% during the forecast period. The prominent players in this market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Genscript Biotech Corporation (US), Takara Bio, Inc. (Japan), Bio-Rad Laboratories (US), Lonza (US), Promega Corporation (US), New England Biolabs (US), Oxford Expression Technologies Ltd. (US), and Synthetic Genomics Inc. (US). |
May 2020 | $ 4950 |
|
Depth Filtration Market by Media Type (Cellulose, Activated Carbon), Product (Capsule, Sheet, Module), Application(Final Product Processing (Biologics), cell Clarification, Viral Clearance, Operation Scale (Manufacturing, Lab) - Global Forecast to 2025The depth filtration market is expected to grow from USD 1.7 billion in 2019 to USD 2.9 billion by 2025 at a compound annual growth rate (CAGR) of 9.0% during the forecast period.The major companies operating in the global depth filtration market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), GE Healthcare (US), 3M (US), Parker Hannifin Corporation (US), Porvair Filtration Group (UK), ErtelAlsop (US), Amazon Filters Ltd. (UK), Meissner Filtration Products, Inc. (US), Donaldson Comany, Inc. (US), Eaton Corporation (Ireland), Saint-Gobain Performance Plastics (France), Clariance Technique (Australia), Repligen Corporation (US), Microfilt India Pvt. Ltd. (India), Graver Technologies (US), Gusmer Enterprises (US), Filtrox AG (Switzerland), Pure Process (UK), Membrane Solutions (US), Allied Filter Systems Ltd. (UK), Pentair (US), Membracon (UK), and Phenomenex (US) |
April 2020 | $ 4950 |
|
HLA Typing for Transplant Market by Technology (PCR (SSO, SSP, Real Time), Sequencing (NGS, Sanger)), Product (Instrument, Reagent, Software), Application (Chimerism, Antibody Screening), End User (Hospital, Diagnolab, Academia) - Global Forecast to 2025The HLA Typing for Transplant Market is expected to grow from USD 656 million in 2019 to USD 968 million by 2025, at a CAGR of 6.7% during the forecast period. Some of the prominent players in the HLA typing for the transplants market are Thermo Fisher Scientific, Inc. (US), QIAGEN N.V. (Netherlands), Illumina (US), CareDx, Inc. (US), and Immucor, Inc. (US). Others are Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Hologic, Inc. (US), Luminex (US), Biofortuna (UK), Takara Bio (Japan), Omixon (Hungary), Becton, Dickinson and Company (US), Fujirebio, Inc. (Japan), and TBG Diagnostics Ltd. (Australia) |
March 2020 | $ 4950 |
|
Glycomics / Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (Mass Spectrometry, Chromatography), Carbohydrates, Reagents & Chemicals), Application (Disease Diagnostics), End-User (Academic) -Global Forecasts to 2025The glycomics / glycobiology market is expected to grow from USD 1.0 billion in 2020 to USD 2.0 billion by 2025, at a compound annual growth rate (CAGR) of 13.8%.during the forecast period.The prominent players operating in the glycomics market include Merck KGaA (Germany), Agilent Technologies (US), Thermo Fisher Scientific (US), New England Biolabs (US), Shimadzu Corporation (Japan), Takara Bio (Japan), S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Waters Corporation (US), Asparia Glycomics S.L. (Spain), Bio-Techne (US), Bruker Corporation (US), Danaher Corporation (US), RayBiotech (US), Z Biotech (US), Chemily Glycoscience (US), Dextra Laboratories (UK), Lectenz Bio (US), and Ludger Ltd. (UK). |
March 2020 | $ 4950 |
|
Neuromodulation Market by Technology- Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation), Application (Ischemia, Chronic Pain, Parkinson’s, Depression, Tremor, Epilepsy, Migraine) - Global Forecast to 2025The neuromodulation market is expected to grow from USD 5.8 billion in 2020 to USD 8.8 billion by 2025, at a compound annual growth rate (CAGR) of 8.6% during the forecast period.The prominent players in the neuromodulation market include Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), LivaNova (UK), Synapse Biomedical, Inc. (US), Nevro Corporation (US), NeuroSigma (US), NeuroPace (US), Neuronetics (US), and BioControl Medical (Israel). Major players have focused on product launches, agreements, and partnerships to increase their shares in the global neuromodulation market. |
February 2020 | $ 4950 |
|
Sterile Filtration Market by Product (Cartridge, Capsule, Syringe), Application (Fill Finish Process, Bioburden Reduction), Membrane (Nylon, PTFE, PES, PVDF), Pore Size (0.2 Microns), End User (Pharmaceutical, Biotechnology, F&B) - Global Forecast to 2025The sterile filtration market is expected to grow from USD 4.7 billion in 2019 to USD 7.4 billion by 2025, at a compound annual growth rate (CAGR) of 8.0% during the forecast period.The major companies in the tangential flow filtration market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), 3M (US), and Parker Hannifin Corporation (US). |
February 2020 | $ 4950 |
|
Single-cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instruments), Technique (Flow Cytometry, NGS, PCR, Mass Spectrometry, Microscopy), Application (Research, Medical Application), End User - Global Forecasts to 2025The single-cell analysis market is expected to grow USD 5.6 billion by 2025 from USD 2.1 billion in 2019, at a CAGR of 17.8% during the forecast period. Prominent players in the single-cell analysis market include Becton, Dickinson and Company (US), Danaher Corporation (US), Merck Millipore (US), QIAGEN (Netherlands), Thermo Fisher Scientific (US), General Electric Company (US), 10x Genomics (US), Promega Corporation (US), Illumina (US), Bio-Rad Laboratories (US), Fluidigm Corporation (US), Agilent Technologies (US), NanoString Technologies (US), Tecan Group (Switzerland), Sartorius AG (Germany), Luminex Corporation (US), Takara Bio (Japan), Fluxion Biosciences (US), Menarini Silicon Biosystems (Italy), and LumaCyte (US). |
February 2020 | $ 4950 |
|
Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), by Technology (Gene Synthesis, Bioinformatics), by Application (Tissue Regeneration, Biofuel, Renewable Energy, Food & Agriculture, Bioremediation) - Global Forecast to 2025The synthetic biology market is expected to grow from USD 6.8 billion in 2020 to USD 19.8 billion by 2025, at a compound annual growth rate (CAGR) of 23.9%. during the forecast period.The prominent players in the synthetic biology market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris, Inc. (US), Intrexon Corporation (US), GenScript Biotech Corporation (China), Twist Bioscience (US), Synthetic Genomics, Inc. (US), Codexis, Inc. (US), Synthego Corporation (US), Creative Enzymes (US), Eurofins Scientific (Luxembourg), Cyrus Biotechnology Inc. (US), ATUM (US), TeselaGen (US), Arzeda (US), Integrated DNA Technologies, Inc. (US), and New England Biolabs (US). |
February 2020 | $ 4950 |
|
Protein Engineering Market by Technology (Rational Design, Irrational Design), Product & Service (Instrument, Consumables), Protein Type (Monoclonal Antibodies, Insulin), End User (Academics Institutes, Biopharmaceuticals, CROs) - Global Forecast to 2024The global protein engineering market is expected to grow USD 3.9 billion by 2024 from USD 2.2 billion in 2019, at a CAGR of 12.4% during the forecast period. The major companies operating in the global protein engineering market include Thermo Fisher Scientific (US), Danaher Corporation (US), Agilent Technologies (US), and Bio-Rad Laboratories (US). |
January 2020 | $ 4950 |
|
Animal Growth Promoters and Performance Enhancers Market by Product Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probioitcs & Prebiotics, Phytogenics), Animal (Poultry, Porcine, Livestock, Aquaculture) - Global Forecast to 2024The Animal Growth Promoters and Performance Enhancers Market is expected to grow from USD 13.9 billion in 2019 to USD 18.5 billion by 2024, at a CAGR of 5.9% during the forecast period. The key players in the global animal growth promoters and performance enhancers market are Merck and Co. Inc. (US), Cargill Inc. (US), Royal DSM N.V. (Germany), Vetoquinol (France), Bupo Animal Health (SA), Elanco Animal Health Inc. (US), CHR Hansen (UK), Novus International Inc. (US), Associated British Foods (ABF) plc (UK), Alltech Inc. (US), ERBER AG (UK), Archer-Daniels-Midland Company (US), Phibro Animal Health Corporation (US), Kemin Industries (US), SHV (Nutreco) (UK), BASF SE (UK), Lallemond Inc. (Canada), Bluestar Adisseo Company (France), Evonik Industries AG (UK), and Land O' Lake Inc.(US). |
January 2020 | $ 4950 |
|
Flow Cytometry Market by Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents, Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical Laboratories, Pharma-Biotech Cos), Application - Global Forecasts to 2025The flow cytometry market is expected to grow from USD 4.0 billion in 2019 to USD 6.4 billion by 2025, at a compound annual growth rate (CAGR) of 8.3% during the forecast period.Becton, Dickinson and Company (US), Beckman Coulter, Inc. (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Sysmex Partec GmbH (Germany), Luminex Corporation (US), Miltenyi Biotec GmbH (Germany), Bio-Rad Laboratories, Inc. (US), Sony Biotechnology, Inc. (US), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Enzo Life Sciences, Inc. (US), Stratedigm, Inc. (US), Cytonome/ST LLC (US), Cytek Biosciences (US), and Apogee Flow Systems Ltd. (UK) are the key players operating in the global market. |
January 2020 | $ 4950 |
|
Gene Therapy Market by Vectors [Non-viral (Oligonucleotides), Viral (Retroviral (Gammaretroviral, Lentiviral)), Adeno-associated], Indication (Cancer, Neurological Diseases), Delivery Method (In Vivo, Ex Vivo), Region - Global Forecast to 2024The gene therapy market is expected to grow from USD 3.8 billion in 2019 to USD 13.0 billion by 2024, at a compound annual growth rate (CAGR) of 27.8%. during the forecast period.The prominent players operating in the gene therapy market include Biogen (US), Novartis AG (Switzerland), Gilead Sciences, Inc. (US), Spark Therapeutics, Inc. (US), MolMed S.p.A. (Italy), Orchard Therapeutics plc. (UK), SIBIONO (China), Shanghai Sunway Biotech Co., Ltd. (China), bluebird bio, Inc. (US), Human Stem Cells Institute (Russia), AnGes, Inc. (Japan), Alnylam Pharmaceuticals, Inc. (US), Sarepta Therapeutics (US), Jazz Pharmaceuticals, Inc. (Ireland), Akcea Therapeutics (US), and Dynavax Technologies (US). |
January 2020 | $ 4950 |
|
Isothermal Nucleic Acid Amplification Technology/INAAT Market by Product (Assay & Kit, System), Application (Infectious disease [HIV, Influenza], Blood Screening), Type (LAMP, SDA, NASBA, HDA), End User, Region - Global Forecast to 2024The isothermal nucleic acid amplification technology (INAAT) market is expected to grow from USD 1.9 billion in 2019 to USD 3.3 billion in 2024, at a compound annual growth rate (CAGR) of 11.0% during the forecast period.The major companies in the INAAT market include Grifols S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories, Inc. (US), Becton, Dickinson & Company (US), and Meridian Bioscience (US). |
January 2020 | $ 4950 |
|
Laboratory Filtration Market by Product (Filtration Assembly, Filter Media Accessories), Technology (Ultrafiltration, Microfiltration, Nanofiltration, RO), End User (Pharmaceutical, Biopharmaceutical Company, F&B), Region - Global Forecast to 2025The Laboratory Filtration Market is expected to grow from USD 2.5 billion in 2019 to USD 4.1 billion by 2025, at a CAGR of 8.3% during the forecast period. The prominent players in the global laboratory filtration market are Merck Millipore (US), Danaher Corporation (US), Sartorius Ag (Germany), 3M Company (US), GE Healthcare (US), GEA GROUP AKTIENGESELLSCHAFT (Germany), Cantel Medical Corporation (US), Thermo Fisher Scientific (US), Veolia Water Technologies (France), Avantor, Inc (US), GVS S.p.A (Italy), MANN+HUMMEL (Germany), Agilent Technologies, Inc (US), Ahlstrom-Munksjö (Finland), MACHEREY-NAGEL GmbH & Co. KG (Germany), AMD Manufacturing, Inc (Canada), Koch Membrane Systems (US), Cole-Parmer (US), AQUAPORIN A/S (Denmark), and Sterlitech Corporation (US). |
January 2020 | $ 4950 |
|
Tangential Flow Filtration Market by Product (TFF System, Membrane Filter), Application (Bioprocess, Viral Vector Purification), Technique (Ultrafiltration, Microfiltration), Material Type (PES/PS Membrane), Region - Global Forecast to 2024The Tangential Flow Filtration Market is expected to grow from USD 944 million in 2019 to USD 1,590 million by 2024, at a CAGR of 11.0% during the forecast period. The major companies in the global TFF market are Merck Millipore (US), Danaher Corporation (US), Sartorius AG (Germany), GE Healthcare (US), and Repligen Corporation (US). |
January 2020 | $ 4950 |
|
Pharmaceutical Membrane Filtration Market by Product (Filter, Systems), Technique (Microfiltration, Ultrafiltration), Material (PES, PVDF, PTFE, PCTE), Application (Final Product (Sterile), Raw Material (Bioburden), Cell Separation, Air) - Global Forecast to 2024The global pharmaceutical membrane filtration market is expected to grow USD 8.6 billion by 2024, growing at a CAGR of 11.0% during the forecast period. The major companies operating in the pharmaceutical membrane filtration market include Merck Millipore (Germany), Danaher (US) and Sartorius Stedim Biotech (France). |
December 2019 | $ 4950 |
|
3D Cell Culture Market by Product (Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharmaceutical, Biotech, Cosmetics), Region - Global Forecast to 2024The 3D Cell Culture Market is expected to grow from USD 892 million in 2019 to USD 1,846 million by 2024, at a CAGR of 15.7% during the forecast period. Some of the prominent players offering 3D cell culture products include Thermo Fisher Scientific (US), Corning Incorporated (US), Merck KGaA (Germany), Lonza AG (Switzerland), REPROCELL Incorporated (Japan), TissUse (Germany), InSphero (Switzerland), Synthecon (US), 3D Biotek (US), CN Bio (UK), Hamilton Company (US), MIMETAS (Netherlands), Emulate (US), HìREL Corporation (US), QGel SA (Switzerland), SynVivo (US), Advanced BioMatrix (US), Greiner Bio-One International (Austria), and PromoCell (Germany). These players adopted various growth strategies, such as product launches & upgrades, expansions, acquisitions, partnerships, agreements, and collaborations to further expand their presence in the global market. |
December 2019 | $ 4950 |
|
Single Use Assemblies Market by Product (Bag Assembly, Filtration Assembly, Bottle Assembly, Mixing Assembly), Application (Filtration, Storage), Solution (Standard, Customized), End User (Pharmaceutical Companies, CMOs and CROs) - Global Forecast to 2024The single use-assemblies market is expected to grow from USD 805 million in 2019 to USD 1,825 million in 2024, at a compound annual growth rate (CAGR) of 16.5% during the forecast period.The major companies in the global single-use assemblies market include Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher (US), Merck Millipore (Germany)), and GE Healthcare (US). |
December 2019 | $ 4950 |
|
Next-generation Sequencing (NGS) Market by Product (NOVASEQ, NEXTSEQ, SEQUEL, NANOPORE), Consumables, Bioinformatics, Services (EXOME, RNA, DENOVO), Technology (ION, SMRT), Application (Diagnostics, Cancer), End User, Region - Global Forecast to 2025The next-generation sequencing (NGS) market is projected to reach USD 24.4 billion by 2025 from USD 7.8 billion in 2019, at a CAGR of 20.9% during the forecast period. Some of the prominent players in the NGS market include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Intrexon Bioinformatics GmbH (Germany), Partek Incorporated (US), DNASTAR, Inc. (US), DNAnexus (US), SciGenom Labs Pvt. Ltd. (India), GENEWIZ (US), Takara Bio Inc. (Japan), Eurofins Scientific (Luxembourg), 10x Genomics (US), F. Hoffmann-La Roche Ltd. (Switzerland), Becton Dickinson and Company (US), Danaher (US), Lexogen GmbH (Austria), Tecan Trading AG (Switzerland), Zymo Research (US), Oxford Nanopore Technologies (UK), Agilent Technologies, Inc. (US), and QIAGEN (Netherlands). |
November 2019 | $ 4950 |
|
Cell Analysis Market by Product [Microscope, Spectrophotometers, Flow cytometry (Software, Accessories)], Process (Cell Viability, Cell Proliferation, Signal Transduction), End User (Pharma, Research, Biotechnology Companies) - Global Forecast to 2024The cell analysis market is expected to grow from USD 16.0 billion in 2019 to USD 22.7 billion by 2024, at a compound annual growth rate (CAGR) of 7.2%. during the forecast period.The prominent players operating in the cell analysis market are Danaher Corporation (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), GE Healthcare (US), Agilent Technologies, Inc. (US), Olympus Corporation (Japan), PerkinElmer, Inc. (US), Promega Corporation (US), Tecan Group (Switzerland), Miltenyi Biotec (Germany), Carl Zeiss (Germany), Bio-Rad Laboratories Inc (US), and Sysmex Corporation (Japan). |
October 2019 | $ 4950 |
|
3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser), Bioink (Natural, Synthetic, Hybrid)), Material (Hydrogel, Living Cells), Application (Skin, Drug Research), End user (Biopharma, Academia) - Global Forecast to 2024The 3D Bioprinting Market is expected to grow from USD 651 million in 2019 to USD 1,647 million by 2024, at a CAGR of 20.4% during the forecast period. The major players in the market include Organovo Holdings Inc. (US), CELLINK (Sweden), Allevi Inc. (US), Aspect Biosystems Ltd. (Canada), EnvisionTEC GmbH (Germany), Cyfuse Biomedical K.K. (Japan), Poietis (France), TeVido BioDevices (US), Nano3D Biosciences, Inc. (US), ROKIT Healthcare (South Korea), Digilab Inc. (US), regenHU (Switzerland), GeSiM (Germany), Advanced Solutions Life Sciences (US), and Regenovo Biotechnology Co., Ltd. (China) among others. |
September 2019 | $ 4950 |
|
NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024The NGS-based RNA-sequencing market is expected to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a compound annual growth rate (CAGR) of 20.0%. during the forecast period.Illumina (US), Thermo Fischer Scientific (US) and Oxford Nanopore (UK), Agilent Technologies, Inc. (US), BGI (China), PerkinElmer Inc. (US), QIAGEN (Germany), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd (Switzerland), Takara Bio Inc. (Japan), GENEWIZ, Inc. (US), Hamilton Company (US), Macrogen (South Korea), Zymo Research (US), and Tecan Genomics, Inc. among others are the major players operating in the NGS-based RNA-sequencing market. |
September 2019 | $ 4950 |
|
In-Vitro Toxicology/Toxicity Testing Market by Product & Services, Toxicity Endpoint & Test (Carcinogenicity, Dermal Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays), Industry (Pharmaceutical, Cosmetics), Region-Global Forecast to 2024The In-Vitro Toxicology/Toxicity Testing Market is expected to grow from USD 8.1 billion in 2019 to USD 12.7 billion by 2024, at a CAGR of 9.3% during the forecast period. The prominent players in the in-vitro toxicology testing market include Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US). |
September 2019 | $ 4950 |
|
Metagenomic Sequencing Market by Workflow (Sample Preparation, Data Analysis), Product & Services (Reagents, Consumables, Instruments), Technology (Shotgun, 16s Rrna, Whole-Genome), Application (Diagnostic, Soil Microbiome) - Global Forecast to 2024The metagenomic sequencing market is expected to grow from USD 1.0 billion in 2019 to USD 2.3 billion by 2024, at a compound annual growth rate (CAGR) of 17.0% during the forecast period.The major players operating in the global metagenomic sequencing market are Illumina, Inc. (US), Thermo Fisher Scientific, Inc (US), QIAGEN N.V. (Netherlands), PerkinElmer (US), Oxford Nanopore Technologies Ltd (UK), BGI Group (China), Macrogen Inc. (South Korea), GENEWIZ (US), Eurofins Scientific (Luxembourg), Novogene Corporation (China), Zymo Research Corporation (US), NuGEN Technologies, Inc (US), IntegraGen SA (France), Microsynth AG (Switzerland), and DNAStar, Inc (US). |
September 2019 | $ 4950 |
|
Non Invasive Prenatal Testing (NIPT) Market by Product (Consumables, Reagent, Ultrasound, NGS, PCR, Microarray), Services, Method (cfDNA, Biochemical Markers), Application (Aneuploidy, Microdeletion) & End-User (Hospital, Labs)-Global Forecasts to 2024The Non Invasive Prenatal Testing (NIPT) Market is expected to grow from USD 3.9 billion in 2019 to USD 7.3 billion by 2024, at a CAGR of 13.5% during the forecast period. The prominent players in the market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), GE Healthcare (US), BGI (China), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer Inc. (US), Laboratory Corporation of America Holdings (US), Natera, Inc. (US), and Yourgene Health (UK) |
September 2019 | $ 4950 |
|
Human Microbiome Market by Product (Prebiotic, Probiotic, Food, Medical Food, Drug), Application (Therapeutic), Disease (Infectious, Metabolic/Endocrine, Cancer, Blood, Neurological), Research Technology (Proteomics, Metabolomics) - Global Forecast to 2027The Human Microbiome Market is expected to grow from USD 942 million in 2024 to USD 1,731 million by 2027, at a CAGR of 22.5% during the forecast period. On the basis of region, the global human microbiome market is segmented into four major geographies— North America, Europe, the Asia Pacific, and the Rest of the World (RoW). Europe is expected to account for the largest share of the global human microbiome market in 2022. The large share of this regional segment is mainly due to the high research activity in this region. The major players in the human microbiome market include Enterome Bioscience (France), 4D Pharma (UK), and Seres Therapeutics (US). |
September 2019 | $ 4950 |
|
Cryotherapy Market by Product (Cryosurgery Devices, Localized Cryotherapy Devices, Cryosaunas), Application (Surgical Application, Pain Management, Health & Beauty), End User (Hospitals & Specialty Clinics, Spas) - Global Forecast to 2024The Cryotherapy Market is expected to grow from $206 million in 2019 to $319 million by 2024, at a CAGR of 9.1% during the forecast period. The major players operating in the cryotherapy market include Medtronic (Ireland), Galil Medical (US), and CooperSurgical (US). Other players involved in this market include Impact Cryotherapy (US), Zimmer MedizinSysteme (Germany), Metrum Cryoflex (Poland), Brymill Cryogenic Systems (UK), Erbe Elektromedizin (Germany), CryoConcepts (US), US Cryotherapy (US), Professional Products (US), and Kriosystem Life (Poland). |
July 2019 | $ 4950 |
|
Cell Culture Market by Product (Consumables (Media, FBS), Equipment (Bioreactor, Centrifuge, Incubator, Microscope, Autoclave)), Application (Stem Cell, Vaccines, Therapeutic proteins), End User (Pharma, Research Institutes) - Global Forecast to 2024The cell culture market is expected to reach USD 29.2 billion by 2024 from USD 16.0 billion in 2019, at a CAGR of 12.7% during the forecast period. This market is experiencing significant growth due to the increasing demand for monoclonal antibodies, rising funding for cell-based research, growing preference for single-use technologies, growing awareness about the benefits of cell culture-based vaccines, and increasing focus on personalized medicine. The prominent players operating in this market include Becton, Dickinson and Company (US), Thermo Fisher Scientific (US), Merck KGaA (Germany), HiMedia Laboratories (India), GE Healthcare (US), Lonza (Switzerland), Corning Incorporated (US), Sartorius AG (Germany), Eppendorf AG (Germany), PromoCell GmbH (Germany), Danaher Corporation (US), Irvine Scientific (US), InvivoGen (US), and CellGenix GmbH (Germany). |
July 2019 | $ 4950 |
|
Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural) & By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) - Global Forecast to 2024The biomaterials market is projected to reach USD 207 billion by 2024 from USD 105 billion in 2019, at a CAGR of 14.5% between 2019 and 2024. Factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases are driving the growth of the biomaterials market. Prominent players in the biomaterials market are Royal DSM (Netherlands), BASF SE (Germany), Corbion (Netherlands), Carpenter Technology Corporation (US), Evonik Industries (Germany), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), Celanese Corporation (US), CoorsTek Inc. (US), CeramTec (Germany), and GELITA AG (Germany). |
June 2019 | $ 4950 |
|
Protein Stability Analysis Market by Product (Assay and Reagent, Instrument), Technique (Chromatography, Spectroscopy (DLS, Fluorescence Spectroscopy), SPR, DSF), End User (Pharmaceutical & Biotech Companies, Research Institute) - Global Forecast to 2024The market for protein stability analysis is expected to grow from USD 1.2 billion in 2018 to USD 2.1 billion by 2024, at a CAGR of 10.0 % during the forecast period. The growth of the protein stability analysis market is primarily driven by the growing adoption of open innovation models in pharmaceutical & biotechnology companies and increasing pharmaceutical outsourcing. The major protein stability analysis vendors include PerkinElmer (US), Thermo Fisher Scientific, Inc. (US), Unchained Labs (US), NanoTemper Technologies (US), Waters Corporation (US), Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), GE Healthcare (US), Malvern Panalytical Ltd (Spectris company) (US), Enzo Life Sciences, Inc. (US), and Horiba, Ltd (Japan). |
June 2019 | $ 4950 |
|
Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents, Software, Services), Application (Clinical, Oncology, Forensics), End-user (Hospitals, Diagnostic Labs, Academia, Pharma-Biotech, CRO) - Global Forecast to 2024The global dPCR and qPCR market is projected to reach USD 6.3 billion by 2024 from USD 4.1 billion in 2019, at a CAGR of 8.8% from 2019 to 2024. The growth of this market is primarily driven by the rising incidences of target diseases and genetic disorders; continuous technological advancements in PCR technologies, the development of miniaturized portable instruments, and incorporation of robotics; increasing investments, funds, and grants for research activities; increasing use of biomarker profiling for disease diagnostics; and the successful completion of the Human Genome Project. As of 2018, the dPCR and qPCR market is dominated by Thermo Fisher Scientific, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Germany), and Takara Bio, Inc. (Japan). |
May 2019 | $ 4950 |
|
NGS Sample Preparation Market by Product (Reagent, Workstations), Workflow (Library Preparation [DNA, RNA], Target Enrichment), Application (Infectious Disease, Cancer Diagnostics), Technology (SMRT, Nanopore) - Forecast to 2024The NGS sample preparation market is projected to grow from USD 1.1 billion in 2019 to USD 2.7 billion by 2024, at a CAGR of 18.7% during the forecast period. Factors such as advancements in NGS platforms, reduced cost of sequencing, and improving reimbursement scenario for NGS-based diagnostic tests are driving the growth of this market. However, while the costs involved in NGS have reduced to some extent, they have not reached a level where broad adoption across developing markets can be achieved. This is a key restraint for market growth.Illumina Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (US), Beckman Coulter (a subsidiary of Danaher), Becton, Dickinson and Company (BD) (US), and Pacific Biosciences of California (US). |
May 2019 | $ 4950 |
|
Oligonucleotide Synthesis Market by Product (Probe, Linkers, Adaptor, Drugs, Reagent, Equipment), Type (Custom, Pre Design), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Hospital, Pharmaceutical, Biotechnology) - Global Forecast to 2024The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7% during the forecast period. This market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques. The prominent players operating in the oligonucleotide synthesis market include BioAutomation Corporation (US), LGC Biosearch Technologies (US), Eurogentec (Belgium), GeneDesign, Inc. (Japan), Sarepta Therapeutics (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), GenScript, Inc. (US), Integrated DNA Technologies (IDT, US), Nitto Denko Avecia, Inc. (US), TriLink BioTechnologies (US), Biogen International (US), ATDBio Ltd. (UK), Bio-Synthesis, Inc. (US), Eurofins Genomics (Germany), GE Healthcare (US), Sigma-Aldrich Corporation (a part of Merck KGAA, US), and Sarepta Therapeutics (US). |
April 2019 | $ 4950 |
|
Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Research) - Forecast to 2024The live cell encapsulation market is projected to grow to USD 303 million by 2024 from USD 250 million in 2018, at a CAGR of 3.2% during the forecast period. Growth in the live cell encapsulation market is primarily driven by factors such as the increasing public-private investments to support product development, increasing research to establish the clinical efficacy of cell encapsulation technologies, and rising public awareness related to the clinical role of encapsulated cells in disease management. BioTime, Inc. (US), Viacyte, Inc. (US), and Living Cell Technologies Ltd. (Australia) were the top three players in the live cell encapsulation market. Other prominent players operating in this market include Sigilon Therapeutics, Inc. (US), Evonik Industries (Germany), BÜCHI Labortechnik AG (Germany), Blacktrace Holdings Ltd (UK), and Sernova Corporation (Canada), among others. Furthermore, the key players in the developmental pipeline products in this market include Neurotech Pharmaceuticals, Inc. (US), Gloriana Therapeutics (US), Kadimastem (Israel), Beta-O2 Technologies, Inc. (Israel), Defymed (France), and Altucell, Inc. (US), among others. |
April 2019 | $ 4950 |
|
Regenerative Medicine Market by Type [Cell-Based Immunotherapy & Cell Therapy (Allogeneic & Autologous Products), Tissue Engineering, Gene Therapy], Applications (Wounds & Dermal, Musculoskeletal, Oncology), Region - Global Forecast to 2024The regenerative medicine market is projected to reach USD 38.7 billion by 2024 from USD 13.3 billion in 2019, at a CAGR of 23.8%. Market growth is largely driven by the rising prevalence of chronic diseases and genetic disorders, growing government investments in regenerative medicine research, and the increasing number of regenerative medicine companies globally.Kite Pharma (US), Novartis (Switzerland), Vericel Corporation (US), Integra LifeSciences (US), Wright Medical (US), MiMedx (US), Osiris Therapeutics (US), Stryker Corporation (US), and Spark Therapeutics (US). |
March 2019 | $ 4950 |
|
Cell-based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, Services), Application (Drug Discovery, Research), End User (CROs, Biopharma Companies, Research Institutes), Geography - Global Forecast to 2024The cell-based assays market is projected to reach USD 18.9 billion by 2024 from USD 13.9 billion in 2019, at a CAGR of 6.3%. The growth of this market is majorly driven by the growing preference for cell-based assays, increasing research funding, and the growth in the number of drug discovery activities. However, the high cost of instruments and restrictions on reagent use are the major factors restraining the growth of this market. Thermo Fisher Scientific, Inc. (US), Danaher Corporation (Beckman Coulter, Inc.) (US), Becton, Dickinson and Company (US), GE Healthcare (US), Merck KGaA (Germany), Lonza Group (Switzerland), PerkinElmer, Inc. (US), Charles River Laboratories, Inc. (US), Cell Signaling Technologies (US), Cisbio (US), Cell Biolabs, Inc. (US), and Promega Corporation (US). |
March 2019 | $ 4950 |
|
Reporter Gene Assay Market by Reagents & Assay kits (Luciferase, Green Fluorescent Protein, â-glucuronidase, â-galactosidase), Application (Gene Regulation, Protein Interaction, Cell Signalling Pathways), End Users, Region - Global Forecast to 2024The reporter gene assays market is projected to reach USD 2.6 billion by 2024 from USD 1.6 billion in 2019, at a CAGR of 10.1%. Factors contributing to the growth of this market include increasing funding for cell-based research, growing applications of gene expression, and rising preference for cell-based assays. The prominent players in the reporter gene assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Danaher Corporation (US), Geno Technology (US), Genecopoeia, Inc. (US), InvivoGen (France), PromoCell (Germany), Becton, Dickinson and Company (US), Biotium, Inc. (US), Canvax (Spain), LI-COR, Inc. (US), System Biosciences, LLC (US), Indigo Biosciences, Inc. (US), BioThema (Sweden), Takara Bio Inc (US), BioAssay Systems (US), Cell Biolabs, Inc. (US), BPS Bioscience, Inc (US), Biosynth AG (Switzerland), and Cayman Chemical (US). |
March 2019 | $ 4950 |
|
Genomics Market by Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostic Application, and Precision Medicine), End User (Research Institute) - Global Forecast to 2024The global genomics market is projected to reach USD 35.7 billion by 2024 from USD 18.9 billion in 2019, at a CAGR of 13.5% during the forecast period. Factors such as the rising government funding and growth in the number of genomics projects, decreasing sequencing costs, growing application areas of genomics, and the entry of new players and start-ups in the genomics field are driving the growth of the genomics market. However, the high cost of genomic equipment could limit market growth to a certain extent in the coming years. Thermo Fisher Scientific, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), Eurofins Scientific (Germany), BGI (China), GE Healthcare (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), and Oxford Nanopore Technologies (UK) are the key players operating in the genomics market. |
March 2019 | $ 4950 |
|
miRNA Sequencing and Assay Market by Product (Library Preparation, Consumables), Technology (Sequencing By Synthesis, Nanopore, Ion Semiconductor Sequencing), End User (Research Institute, Academia, CRO), Region - Global Forecast To 2024The miRNA sequencing and assays market is projected to reach USD 343 million by 2024 from USD 182 million in 2018, at a CAGR of 11.2%. Growth in this market is driven by factors such as the advantages of miRNA sequencing over other technologies, increasing research funding for genomics, and the decreasing cost of sequencing.Illumina (US), Thermo Fisher Scientific (US), QIAGEN (Germany), Takara Bio (Japan), NEB (UK), and 5 others. |
March 2019 | $ 4950 |
|
Exosome Research Products Market by Product and Services (Kit, Reagent, Instrument, Service), Application (cancer [lung cancer, prostate cancer, breast cancer]), and End User (Hospitals, Academics, Research Institute) - Global Forecast to 2024The global exosome research products market is projected to reach USD 264 million by 2024 from USD 91 million in 2019, at a CAGR of 23.8% during the forecast period. The growth of this market is driven by factors such as the increasing funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures.Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Bio-Techne (US), System Biosciences, LLC. (US), NX Pharmagen (US), Miltenyi Biotec (Germany), AMS Biotechnology (Europe) Limited (UK), NanoSomiX (US), Lonza (Switzerland), and Norgen Biotek Corp. (Canada) |
February 2019 | $ 4950 |
|
Cell Isolation/Cell Separation Market by Product (Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose), Technique (Filtration), Application (Cancer), End User (Hospitals, Biotechnology) - Global Forecast to 2024The cell isolation market is projected to grow from USD 5.9 billion in 2019 to USD 13.0 billion by 2024, at a CAGR of 17.2% during the forecast period. Growth in the cell isolation market is mainly driven by the growing government funding for cell-based research, increasing number of patients suffering from cancer and infectious diseases, technological advancements, and the growing focus on personalized medicine. The major players in the cell isolation market are Beckman Coulter (US), Becton Dickinson and Company (US), GE Healthcare (US), Merck KgaA (Germany), Miltenyi Biotec (Germany), pluriSelect (Germany), STEMCELL Technologies Inc. (Canada), Terumo BCT (US), Thermo Fisher Scientific (US), and Bio-Rad Laboratories Inc. (US). |
February 2019 | $ 4950 |
|
Proteomics Market by Instrument (Spectroscopy, Chromatography, Electrophoresis, Microfluidics, X-ray Crystallography), Reagents, Services & Software (Protein Identification, Characterization, Bioinformatics), Application - Global Forecast to 2024The proteomics market is projected to reach USD 38.7 billion by 2024 from USD 19.5 billion in 2019, at a CAGR of 14.7%. Growth in this market is driven by an increase in research activity (especially in the areas of personalized medicine and drug discovery). Other market drivers include increasing pharmaceutical and biotechnology R&D expenditure, government funding for proteomics, and technological advancements. In 2018, North America dominated the global proteomics market, followed by Europe. Increasing investments in the development of structure-based drug designs, growing academic and government investments in Genomics and proteomics research, rising demand for high-quality research tools for data reproducibility, and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes are the factors propelling the growth of the market in the region. Prominent players in the proteomics market are Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc.(US), GE Healthcare (US), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Luminex Corporation (US), Bruker Corporation (US), Merck KGaA,(Germany), Waters Corporation (US), PerkinElmer, Inc. (US), Creative Proteomics (US), and Promega Corporation (US). |
February 2019 | $ 4950 |
|
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.
Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement
Connect With Us
Search reports
Biotechnology ›
Information and Communications Technology ›
Semiconductor and Electronics ›
Medical Devices ›
Chemicals ›
Advanced Materials ›
Energy and Power ›
Food and Beverage ›
Aerospace and Defence ›
Healthcare IT ›
Automotive and Transportation ›
Automation and Process Control ›
Agriculture Industry ›
Packaging ›
Pharmaceuticals ›
Building and Construction ›
Mining, Minerals and Metals ›
Analytical and Scientific Instrumentation ›
Engineering Equipment and Devices ›
'Connect With Us
